Home > News > UK nanotech health firm seeks distributor
September 25th, 2007
UK nanotech health firm seeks distributor
Abstract:
UK-based Orla Protein Technologies saw India as a new market for its nanotechnology products.
The UK pound 200,000 company manufactured niche and specialised products like cell culture surfaces, and liquid proteins.
While around 50 per cent of the cell culture surface market was in the US, it was saturated and rigid, claimed Jeremy Lakey, founder and scientific director of Orla.
Orla was in India as the country would be a big market in ten years. The worldwide market for the cell culture nanotechnology sector was estimated at $1 billion, growing at the rate of 10 to 15 per cent.
Source:
business-standard.com
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||